SCHEMBL5587176

SCHEMBL5587176

CCCCCc1c(Cl)c(Cl)c(Cl)c(O)c1OC(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.35
TYMP P19971 3/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
PAK1 Q13153 1/20 0.33
FFAR1 O14842 1/20 0.32
ALDH1A1 P00352 3/20 0.32
SCD O00767 1/20 0.32
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
ESR1 P03372 1/20 0.31
HCAR3 P49019 1/20 0.31
HCAR2 Q8TDS4 1/20 0.31
PLA2G2A P14555 1/20 0.31
PLA2G5 P39877 1/20 0.31
PTPN1 P18031 1/20 0.31
PPARG P37231 1/20 0.31
PPARD Q03181 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5588265 0.98 ALOX5 (0.38) ALOX5TYMPALDH1A1SCDPLA2G2A
SCHEMBL5590107 0.98 ALOX5 (0.38) ALOX5TYMPALDH1A1SCDPLA2G2A
SCHEMBL5592670 0.98 ALOX5 (0.38) ALOX5TYMPALDH1A1SCDPLA2G2A
SCHEMBL5588605 0.98 ALOX5 (0.38) ALOX5TYMPALDH1A1SCDPLA2G2A
SCHEMBL5587791 0.98 ALOX5 (0.38) ALOX5TYMPALDH1A1SCDPLA2G2A
SCHEMBL5587639 0.95 FFAR1 (0.36) ALOX5TYMPMEN1KMT2APAK1
SCHEMBL5588292 0.89 PPARG (0.33) PPARGPPARA
SCHEMBL5586734 0.88 FFAR1 (0.36) ALOX5TYMPMEN1KMT2APAK1
SCHEMBL5588592 0.85 ALOX5 (0.35) ALOX5TYMPMEN1KMT2APAK1
SCHEMBL5587634 0.84 ALOX5 (0.38) ALOX5TYMPALDH1A1SCDPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 ALOX5 188/4885TYMP 3431/4885MEN1 3377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.